Snowden Capital Advisors’s US Physical Therapy USPH Stock Holding History

Snowden Capital Advisors’s Portfolio USPH Stock Details USPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Sell	3,811 -915	-19%	-$62.2K	0.01%	1148
2026 Q1	$356K	Sell	4,726 -232	-5%	-$19K	0.01%	949
2025 Q4	$387K	Sell	4,958 -765	-13%	-$62.1K	0.01%	939
2025 Q3	$486K	Buy	5,723 +123	+2%	+$9.85K	0.01%	792
2025 Q2	$438K	Buy	5,600 +195	+4%	+$14.4K	0.01%	829
2025 Q1	$394K	Sell	5,405 -70	-1%	-$5.87K	0.01%	858
2024 Q4	$486K	Buy	5,475 +740	+16%	+$65.9K	0.02%	786
2024 Q3	$401K	Buy	4,735 +394	+9%	+$35K	0.01%	876
2024 Q2	$401K	Buy	4,341 +262	+6%	+$26.5K	0.01%	854
2024 Q1	$462K	Sell	4,079 -151	-4%	-$15.1K	0.01%	795
2023 Q4	$394K	Sell	4,230 -81	-2%	-$7.13K	0.02%	805
2023 Q3	$395K	Buy	4,311 +6	+0.1%	+$644	0.02%	750
2023 Q2	$523K	Sell	4,305 -694	-14%	-$74.8K	0.02%	710
2023 Q1	$489K	Sell	4,999 -5	-0.1%	-$477	0.02%	742
2022 Q4	$405K	Buy	5,004 +239	+5%	+$20K	0.02%	801
2022 Q3	$362K	Buy	4,765 +339	+8%	+$32.6K	0.02%	806
2022 Q2	$483K	Buy	+4,426	New	+$470K	0.02%	650

Other funds holding USPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SAM

Southernsun Asset Management Memphis, Tennessee $743M AUM 34.03% 1-Year Est. Return

Snowden Capital Advisors's USPH Position: Q2 2026 in Review

Snowden Capital Advisors reduced its US Physical Therapy (USPH) stake by 19% in Q2 2026, selling an estimated $62.2K and leaving 3,811 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #1148.

Snowden Capital Advisors first reported a position in USPH in Q2 2022 and has held it in 17 quarters since. The position peaked at $523K in Q2 2023. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

Snowden Capital Advisors held 3,811 shares of US Physical Therapy worth $262K as of Q2 2026.
Snowden Capital Advisors sold 915 US Physical Therapy shares in Q2 2026, an estimated $62.2K.
US Physical Therapy made up 0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #1148 holding.
Snowden Capital Advisors first reported a position in US Physical Therapy in Q2 2022 and has held it in 17 quarters since.
Snowden Capital Advisors's US Physical Therapy position peaked at $523K in Q2 2023.
217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.